| Size | Price | Stock |
|---|---|---|
| 100mg | $312 | In-stock |
| 500mg | $931 | In-stock |
| 1 g | Get quote | |
| 5 g | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-W010991 |
| M.Wt: | 399.40 |
| Formula: | C20H21N3O6 |
| Purity: | >98 % |
| Solubility: | DMSO : 100 mg/mL (ultrasonic) |
N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly (FAPGG) is a specific substrate of angiotensin converting enzyme (ACE) with a Ki of 2.546×10-4 M. It is used as a chromogenic probe for quantitative detection of ACE activity. N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly can be hydrolyzed by ACE to generate N-[3-(2-furyl)acryloyl]-Phe (FAP) and Gly-Gly, and the ACE inhibitory effect is monitored by photometry. FAPGG competitively binds to the active center of ACE and is a key tool for screening ACE inhibitors such as Captopril (HY-B0368) and Dioscorin. Its reversible mechanism of action supports hypertension research and drug development targeting the renin-angiotensin system[1].
In Vitro:In the spectrophotometric ACE inhibition assay, N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly (FAPGG; 1×10-3-1×10-4 M; 5 min) is hydrolyzed by ACE with a Km of 2.546×10-4 M[1].
In the TLC-based ACE activity assay, N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly (FAPGG; 5×10-4 M; 10 min) reduces FAP production in the dioscorin-treated group, confirming its ACE inhibitory effect[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.